250 related articles for article (PubMed ID: 35994387)
1. Mifepristone: A Safe Method of Medical Abortion and Self-Managed Medical Abortion in the Post-Roe Era.
Schmidt EO; Katz A; Stein RA
Am J Ther; 2022 Sep-Oct 01; 29(5):e534-e543. PubMed ID: 35994387
[TBL] [Abstract][Full Text] [Related]
2. Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision.
Aiken ARA; Wells ES; Gomperts R; Scott JG
JAMA; 2024 May; 331(18):1558-1564. PubMed ID: 38526865
[TBL] [Abstract][Full Text] [Related]
3. History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion.
Baker CN
J Health Polit Policy Law; 2023 Aug; 48(4):485-510. PubMed ID: 36693178
[TBL] [Abstract][Full Text] [Related]
4. Trends in Abortion- and Contraception-Related Internet Searches After the US Supreme Court Overturned Constitutional Abortion Rights: How Much Do State Laws Matter?
Gupta S; Perry B; Simon K
JAMA Health Forum; 2023 Apr; 4(4):e230518. PubMed ID: 37115538
[TBL] [Abstract][Full Text] [Related]
5. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of abortifacients: A review for physicians in the post roe era.
Mazer-Amirshahi M; Ye P
Am J Emerg Med; 2022 Nov; 61():7-11. PubMed ID: 36007432
[TBL] [Abstract][Full Text] [Related]
7. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
[TBL] [Abstract][Full Text] [Related]
8. A national analysis of ED presentations for early pregnancy and complications: Implications for post-Roe America.
Goodwin G; Marra E; Ramdin C; Alexander AB; Ye PP; Nelson LS; Mazer-Amirshahi M
Am J Emerg Med; 2023 Aug; 70():90-95. PubMed ID: 37245403
[TBL] [Abstract][Full Text] [Related]
9. Medical methods for first trimester abortion.
Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
Cochrane Database Syst Rev; 2004; (2):CD002855. PubMed ID: 15106180
[TBL] [Abstract][Full Text] [Related]
10. Medical methods for mid-trimester termination of pregnancy.
Wildschut H; Both MI; Medema S; Thomee E; Wildhagen MF; Kapp N
Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD005216. PubMed ID: 21249669
[TBL] [Abstract][Full Text] [Related]
11. Medical methods for first trimester abortion.
Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
Ferguson I; Scott H
J Obstet Gynaecol Can; 2020 Dec; 42(12):1532-1542.e2. PubMed ID: 32912726
[TBL] [Abstract][Full Text] [Related]
13. "I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
Raifman S; Ralph L; Biggs MA; Grossman D
Reprod Health; 2021 May; 18(1):91. PubMed ID: 33947413
[TBL] [Abstract][Full Text] [Related]
14. Medical methods for first trimester abortion.
Kulier R; Kapp N; Gülmezoglu AM; Hofmeyr GJ; Cheng L; Campana A
Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD002855. PubMed ID: 22071804
[TBL] [Abstract][Full Text] [Related]
15. Medication to Manage Abortion and Miscarriage.
Beaman J; Prifti C; Schwarz EB; Sobota M
J Gen Intern Med; 2020 Aug; 35(8):2398-2405. PubMed ID: 32410127
[TBL] [Abstract][Full Text] [Related]
16. Experiences with misoprostol-only used for self-managed abortion and acquired from an online or retail pharmacy in the United States.
Johnson DM; Ramaswamy S; Gomperts R
Contraception; 2024 Mar; 131():110345. PubMed ID: 38049047
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone Use Among Obstetrician-Gynecologists in Massachusetts: Prevalence and Predictors of Use.
Newton-Hoe E; Lee A; Fortin J; Goldberg AB; Janiak E; Neill S
Womens Health Issues; 2024; 34(2):135-141. PubMed ID: 38129219
[TBL] [Abstract][Full Text] [Related]
18. Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: release date June 2013 SFP guideline #20133.
Perritt JB; Burke A; Edelman AB
Contraception; 2013 Sep; 88(3):341-9. PubMed ID: 23756114
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
20. US Obstetrician-Gynecologists' Perceived Impacts of Post-Dobbs v Jackson State Abortion Bans.
Sabbath EL; McKetchnie SM; Arora KS; Buchbinder M
JAMA Netw Open; 2024 Jan; 7(1):e2352109. PubMed ID: 38231510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
